Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1762617 (
weakness
)
37,932
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
X-linked Charcot-Marie-Tooth disease type 5 (CMTX5) is an X-linked disorder characterized by early-onset sensorineural hearing impairment, peripheral neuropathy, and progressive optic atrophy. It is caused by a loss-of-function mutation in the
phosphoribosyl pyrophosphate synthetase 1
gene (PRPS1), which encodes isoform I of phosphoribosyl pyrophosphate synthetase (
PRS-I
). A decreased activity leads to nonsyndromic sensorineural deafness (DFN2), CMTX5, and Arts syndrome depending upon residual
PRS-I
activity. Clinical and neurophysiological features of pediatric CMTX5 are poorly defined. We report two male siblings with peripheral neuropathy and prelingual sensorineural hearing loss who carried a novel c.319A>G (p.Ile107Val) PRPS1 missense mutation. They exhibited recurrent episodes of transient proximal muscle
weakness
, showing Gowers' sign and waddling gait after suffering from febrile illness. This transient
weakness
has not been previously reported in CMTX5. A patient with Arts syndrome was reported to have transient proximal
weakness
after febrile illness. The transient
weakness
presenting in both CMTX5 and Arts syndrome suggests an overlap of signs and a continuous spectrum of
PRS-I
hypoactivity disease. Children presenting with transient neurological signs should be evaluated for peripheral neuropathy and consider genetic analysis for PRPS1.
...
PMID:X-linked Charcot-Marie-Tooth disease type 5 with recurrent weakness after febrile illness. 3017 96